Sharad B. Murdande, Ph.D.
Affiliations: | 2010 | University of Connecticut, Storrs, CT, United States |
Area:
PharmacyGoogle:
"Sharad Murdande"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Michael J. Pikal | grad student | 2010 | University of Connecticut | |
| (Theoretical and experimental assessment of the solubility advantage of glassy pharmaceuticals over their corresponding crystalline counterparts.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Shah DA, Murdande SB, Dave RH. (2015) A Review: Pharmaceutical and Pharmacokinetic Aspect of Nanocrystalline Suspensions. Journal of Pharmaceutical Sciences |
| Murdande SB, Pikal MJ, Shanker RM, et al. (2011) Solubility advantage of amorphous pharmaceuticals, part 3: Is maximum solubility advantage experimentally attainable and sustainable? Journal of Pharmaceutical Sciences. 100: 4349-56 |
| Murdande SB, Pikal MJ, Shanker RM, et al. (2011) Aqueous solubility of crystalline and amorphous drugs: Challenges in measurement. Pharmaceutical Development and Technology. 16: 187-200 |
| Murdande SB, Pikal MJ, Shanker RM, et al. (2010) Solubility advantage of amorphous pharmaceuticals: II. Application of quantitative thermodynamic relationships for prediction of solubility enhancement in structurally diverse insoluble pharmaceuticals. Pharmaceutical Research. 27: 2704-14 |
| Murdande SB, Pikal MJ, Shanker RM, et al. (2010) Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis. Journal of Pharmaceutical Sciences. 99: 1254-64 |